<DOC>
	<DOCNO>NCT02104193</DOCNO>
	<brief_summary>The purpose study evaluate effect simvastatin combination radiotherapy clinical outcome patient brain metastasis .</brief_summary>
	<brief_title>Simvastatin Effect Radiation Therapy Brain Metastases</brief_title>
	<detailed_description>Despite current advance therapy , outcome patient brain metastasis fatal . New therapeutic approach , radiosensitizing agent , need provide significant survival advantage patient . Statins report enhance efficacy radiotherapy addition neuroprotective effect . The aim study evaluate effect simvastatin efficacy safety radiation therapy patient brain metastasis improve patient ' quality life .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients measurable brain metastasis Age 18 year old Patients plan radiation therapy Renal dysfunction ( 1 upper normal level ) Hepatic dysfunction ( alanine aminotransferase ( ALT ) and/or aspartate aminotransferase ( AST ) &gt; 3 time upper normal level ) Pregnancy lactation . Known hypersensitivity simvastatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>simvastatin</keyword>
	<keyword>radiation therapy</keyword>
</DOC>